
|Articles|August 15, 2003
Topical drop handles moderate inflammation associated with KCS
Fort Lauderdale, FL-Topical loteprednol etabonate 0.5% (Lotemax, Bausch & Lomb) instilled four times daily may be beneficial to treat patients who have keratoconjunctivitis sicca (KCS) with at least a moderate inflammatory component.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Kodiak Sciences releases follow-up, 20-week data from APEX study
2
AAO 2025: Advancements in laser refractive surgery
3
From then to next: Five decades of transformation in ophthalmology
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5


















































.png)


